An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
Sotagliflozin, a dual SGLT1/2 inhibitor, reduces cardiovascular events in people with diabetic kidney disease — ischemic benefits not observed in trials of selective SGLT2 inhibitors.
If you experience any of these symptoms, see your doctor about getting your blood sugar tested: Specialists and researchers don’t know exactly why type 2 diabetes occurs. Some families have higher ...